Auto Draft

8. Option Care Health Inc. (NASDAQ:OPCH)

Option Care extended gains for a second day on Tuesday, nearly hitting its 52-week high, as investors cheered higher preliminary net revenues for full-year 2025.

At intra-day trading, the stock jumped to as much as $35.47—just 6 cents shy of its 52-week high of $35.53. It trimmed gains at the end of the session to finish the day just up by 8.39 percent at $34.75 apiece.

In a statement, Option Care Health Inc. (NASDAQ:OPCH) said that it is gunning for net revenues between $5.645 billion and $5.655 billion for the said period, or the higher end of its earlier guidance range of $5.60 billion to $5.65 billion.

It also expects to report net income between $59.1 million and $62.4 million, as adjusted diluted earnings per share (EPS) of $1.72 to $1.76, versus its previous guidance of $1.68 to $1.72.

Adjusted EBITDA is targeted at $469 million to $473 million, marking a higher low-end of its previous $468 million to $473 million guidance range.

For the fourth quarter alone, net revenues are targeted at $1.46 billion to $1.47 billion, with net income of $59.1 million to $62.4 million.

Diluted EPS is at $0.37 to $0.39, while adjusted EBITDA is pegged at $123.7 million to $127.7 million.

Official results are scheduled to be released next month, alongside its full-year 2026 financial guidance.